John Thero Insider Profile
39 Followers
John Thero, President & CEO, Director at Amarin, holds 3.25M shares in Amarin (Ticker: AMRN), holds 0.00 shares in Chiasma (Ticker: CHMA), holds 22.83K shares in Cyteir Therapeutics (Ticker: CYT).
John Thero's Trading History
| CYTCyteir Therapeutics | May 12, 2022 | ― | Informative Buy | 20.00K | $68.71K | |
| AMRNAmarin | Aug 03, 2021 | President & CEO, Director | Uninformative Buy | 67.65K | $37.02M | |
| CINCCincor Pharma | ― | ― | ― | ― | ||
| CHMAChiasma | ― | ― | ― | $0.00 |
You May Also Like
John Thero insider profile FAQ
What is the percentage of profitable transactions made by John Thero?
The percentage of profitable transactions made by John Thero is 100%.
What is the average return per transaction made by John Thero?
The average return per transaction made by John Thero is 154.40%.
What stocks does John Thero hold?
John Thero holds: AMRN, CHMA, CYT, CINC stocks.
What was John Thero’s latest transaction?
John Thero’s latest transaction was an Uninformative Buy of $67.65K.
What was John Thero's most profitable transaction?
John Thero’s most profitable transaction was an Informative Buy of AMRN stock on December 4, 2017. The return on the trade was 443.20%.
What is John Thero's role in Amarin?
John Thero's role in Amarin is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
